Compare TCRX & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCRX | PODC |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.1M | 63.5M |
| IPO Year | 2021 | N/A |
| Metric | TCRX | PODC |
|---|---|---|
| Price | $1.03 | $2.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 823.7K | 64.7K |
| Earning Date | 11-12-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,423,000.00 | ★ $56,957,000.00 |
| Revenue This Year | $286.83 | $17.39 |
| Revenue Next Year | N/A | $19.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 20.01 |
| 52 Week Low | $0.91 | $1.28 |
| 52 Week High | $3.43 | $2.94 |
| Indicator | TCRX | PODC |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 57.25 |
| Support Level | $0.99 | $2.14 |
| Resistance Level | $1.09 | $2.39 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 35.71 | 55.81 |
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.